The landscape of dementia prognosis has evolved significantly with the appearance of subtle biomarkers, which include amyloid PET scans, tau imaging, and blood-based mostly tests which will detect Alzheimer's pathology several years prior to indications emerge. While these technological advancements symbolize remarkable development in understanding neurodegenerative disorders, they ha... https://fredericl319hqz8.blog-a-story.com/profile